Myron H. Weinberger

Myron H. Weinberger's AcademicInfluence.com Rankings

Myron H. Weinberger

Philosophy

#5489

World Rank

#8306

Historical Rank

Logic

#2759

World Rank

#3794

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Myron H. Weinberger's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Myron H. Weinberger Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Myron H. Weinberger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Salt sensitivity of blood pressure in humans. (1996) (810)
Salt Sensitivity, Pulse Pressure, and Death in Normal and Hypertensive Humans (2001) (518)
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes. (2006) (400)
Eplerenone, a selective aldosterone blocker, in mild-to-moderate hypertension. (2002) (374)
Sodium and Volume Sensitivity of Blood Pressure Age and Pressure Change Over Time (1991) (362)
Cardiovascular and Humoral Responses to Extremes of Sodium Intake in Normal Black and White Men (1979) (355)
Primary aldosteronism: diagnosis, localization, and treatment. (1979) (328)
Salt Sensitivity of Blood Pressure: A Scientific Statement From the American Heart Association. (2016) (281)
Salt Sensitivity and Resistance of Blood Pressure Age and Race As Factors in Physiological Responses (1991) (202)
Antihypertensive therapy and lipids. Evidence, mechanisms, and implications. (1985) (190)
Plasma and Urinary Norepinephrine Values at Extremes of Sodium Intake in Normal Man (1979) (172)
Saline suppression of plasma aldosterone in hypertension. (1971) (163)
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial (2008) (160)
Abnormally sustained aldosterone secretion during salt loading in patients with various forms of benign hypertension; relation to plasma renin activity. (1970) (139)
Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic effects in hypertension. (1983) (134)
Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism. (1973) (120)
Diagnosis of secondary forms of hypertension. A comprehensive protocol. (1977) (118)
Clinical experience with percutaneous transluminal angioplasty (PTA) of stenotic renal arteries. (1980) (115)
Blood pressure and metabolic responses to hydrochlorothiazide, captopril, and the combination in black and white mild-to-moderate hypertensive patients. (1985) (112)
Hypertension induced by oral contraceptives containing estrogen and gestagen. Effects on plasma renin activity and aldosterone excretion. (1969) (109)
Elevated urinary excretion of 18-oxocortisol in glucocorticoid-suppressible aldosteronism. (1984) (109)
Abnormalities of sodium and H2O handling in chronic obstructive lung disease. (1982) (101)
Effects of eplerenone versus losartan in patients with low-renin hypertension. (2005) (101)
Direct Effect of Beta-Adrenergic Stimulation on Renin Release by the Rat Kidney Slice In Vitro (1975) (99)
Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk. (1986) (94)
Plasma renin activity and aldosterone secretion in hypertensive patients during high and low sodium intake and administration of diuretic. (1968) (94)
Plasma aldosterone response to ACTH in primary aldosteronism and in patients with low renin hypertension. (1978) (91)
Familial resemblance in the blood pressure response to sodium restriction. (1987) (91)
Association Between the CYP3A5 Genotype and Blood Pressure (2005) (91)
Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. (2007) (89)
A comparison of two tests for the assessment of blood pressure responses to sodium. (1993) (85)
Blood pressure and metabolic effects of calcium supplementation in normotensive white and black men. (1987) (82)
Comparison of captopril and hydrochlorothiazide alone and in combination in mild to moderate essential hypertension. (1982) (82)
Dietary sodium restriction as adjunctive treatment of hypertension. (1988) (80)
Association of haptoglobin with sodium sensitivity and resistance of blood pressure. (1987) (80)
Ethnic differences in urine concentration: possible relationship to blood pressure. (2007) (79)
Sensitivity and specificity of screening tests for renal vascular hypertension. (1979) (78)
Control of Aldosterone Secretion in the Spontaneously Hypertensive Rat (1975) (78)
Effects of sodium loading, sodium depletion and posture on plasma aldosterone concentration and renin activity in hypertensive patients. (1969) (75)
Controlled Multicenter Study of the Antihypertensive Effects of Lisinopril, Hydrochlorothiazide, and Lisinopril plus Hydrochlorothiazide in the Treatment of 394 Patients with Mild to Moderate Essential Hypertension (1987) (75)
The effects of age, race and heredity on glomerular filtration rate following volume expansion and contraction in normal man (1980) (71)
The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man. (1975) (71)
Percutaneous transluminal dilatation in the treatment of renal vascular hypertension. (1981) (70)
Acute effects of hypoxia on renal and endocrine function in normal humans. (1982) (65)
Comparative effects of candesartan cilexetil and amlodipine in patients with mild systemic hypertension. Comparison of Candesartan and Amlodipine for Safety, Tolerability and Efficacy (CASTLE) Study Investigators. (2001) (64)
The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women. (1977) (63)
The blood pressure effects of calcium supplementation in humans of known sodium responsiveness. (1993) (63)
The blood pressure-raising effects of high dietary sodium intake: racial differences and the role of potassium. (1982) (60)
Effect of hypoxemia on sodium and water excretion in chronic obstructive lung disease. (1985) (59)
Dynamic Responses of Active and Inactive Renin in Normal and Hypertensive Humans (1977) (59)
Diuretics and Their Side Effects Dilemma in the Treatment of Hypertension (1988) (58)
Genetic Influences on the Response to Dietary Salt Reduction, Acute Salt Loading, or Salt Depletion in Humans (1988) (58)
Studies on plasma vasopressin and the renin-angiotensin-aldosterone system in chronic obstructive lung disease. (1977) (57)
Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan). (1979) (56)
Sequential changes in the renin--angiotensin--aldosterone systems and plasma progesterone concentration in normal and abnormal human pregnancy. (1976) (55)
Familial, dexamethasone-suppressible, normokalemic hyperaldosteronism. (1980) (54)
Treatment of hypertension in the 1990s. Optimizing the benefit of blood pressure reduction by minimizing risk factors for cardiovascular disease. (1987) (54)
Salt Sensitivity Is Associated With an Increased Mortality in Both Normal and Hypertensive Humans (2002) (53)
Renal Vascular Hypertension (1986) (52)
Anomalous postural aldosterone response in glucocorticoid-suppressible hyperaldosteronism. (1981) (52)
The Antihypertensive Effect of Pregnancy in Spontaneously Hypertensive Rats (1976) (52)
Blood pressure response to potassium supplementation in normotensive adults and children. (1987) (51)
Hormonal abnormalities affecting sodium and water balance in acute respiratory failure due to chronic obstructive lung disease. (1984) (48)
Evaluation of diagnostic tests in the differential diagnosis of primary aldosteronism: unilateral adenoma versus bilateral micronodular hyperplasia. (1993) (48)
Renin release by rat kidney slices in vitro: effects of cations and catecholamines. (1974) (48)
Effect of chlorothiazide and sodium on vascular responsiveness to angiotensin II. (1972) (47)
Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension (2009) (47)
Factors associated with veterans' decisions about living wills. (1992) (46)
Estrogen attenuation of the development of hypertension in spontaneously hypertensive rats. (1977) (45)
The role of ACTH in the episodic release of aldosterone in patients with idiopathic adrenal hyperplasia, hypertension, and hyperaldosteronism. (1976) (42)
The prediction of anatomical morphology of primary aldosteronism using serum 18-hydroxycorticosterone levels. (1985) (42)
Pathogenesis of salt sensitivity of blood pressure (2006) (42)
Angiotensin Converting Enzyme Inhibitors Enhance the Antihypertensive Efficacy of Diuretics and Blunt or Prevent Adverse Metabolic Effects (1989) (40)
Genetic and pathophysiologic studies of a new kindred with glucocorticoid-suppressible hyperaldosteronism manifest in three generations. (1981) (40)
Rapid cyclic fluctuations of blood pressure associated with an adrenal pheochromocytoma. (1984) (39)
Hypertension in African Americans: the role of sodium chloride and extracellular fluid volume. (1996) (39)
Sodium sensitivity of blood pressure. (1993) (39)
Short‐term augmented calcium intake has no effect on sodium homeostasis (1986) (39)
Renal Modulation of Urinary Catecholamine Excretion During Volume Expansion in the Dog (1980) (38)
Vascular compartmentalization of plasma norepinephrine in normal man: the relationships between venous and arterial norepinephrine concentration and the urinary excretion of norepinephrine. (1979) (38)
Childhood primary aldosteronism due to an adrenal adenoma: preoperative localization by adrenal vein catheterization. (1980) (38)
Review of Salt Restriction and the Response to Antihypertensive Drugs Satellite Symposium on Calcium Antagonists (1988) (37)
Intervention in patients with renovascular hypertension and renal insufficiency. (1983) (37)
Influence of Race, Sex, and Blood Pressure on Erythrocyte Sodium Transport in Humans (1988) (37)
Stimulation of aldosterone secretion by metoclopramide in humans: apparent independence of renal and pituitary mediation. (1981) (36)
Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism. (1983) (34)
An extrarenal source of "renin-like" activity in anephric man. (1977) (34)
Increase in plasma norepinephrine during prazosin therapy for chronic congestive heart failure. (1981) (34)
Effects of age, race, gender, blood pressure, and estrogen on arterial compliance. (2002) (34)
Percutaneous transluminal angioplasty for renal artery stenosis in a solitary functioning kidney. (1979) (34)
Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients. (1982) (34)
Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. (2009) (34)
Low renin hypertension: a current review of definitions and controversies. (1979) (32)
Pseudohypoaldosteronism due to Sweat Gland Dysfunction (1976) (31)
The Effects of Amlodipine Compared to Losartan in Patients With Mild to Moderately Severe Hypertension (2003) (31)
The effects of angiotensin-converting enzyme inhibition on sodium handling in patients with advanced chronic obstructive pulmonary disease. (1987) (30)
The effects of dopamine on renin release in vitro. (1977) (28)
Triamterene‐thiazide combination: Alternative therapy for primary aldosteronism (1981) (27)
Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism. (1984) (27)
Renal and hormonal responses to acute hypoxia in normal individuals. (1985) (27)
An Extrarenal Source of “Renin‐Likerdquo; Activity in Anephric Man (1977) (27)
Salt sensitivity as a predictor of hypertension. (1991) (27)
Racial differences in renal sodium excretion: relationship to hypertension. (1993) (26)
Sodium and blood pressure 2003 (2004) (25)
Evidence for a Physiological Role of Renal Sympathetic Nerves in Adrenergic Stimulation of Renin Release in the Rat (1976) (24)
Radiology in primary hyperaldosteronism. (1976) (24)
Salt sensitive human hypertension. (1991) (24)
Salt Loads Raise Plasma Fatty Acids and Lower Insulin (1991) (23)
The effect of supine and lateral recumbency on plasma renin activity during pregnancy. (1973) (23)
Sodium chloride and blood pressure. (1987) (23)
The renin-angiotensin-aldosterone system in Cushing's syndrome and pheochromocytoma. (1983) (23)
Mechanisms of diuretic effects on carbohydrate tolerance, insulin sensitivity and lipid levels. (1992) (23)
Salt sensitivity: does it play an important role in the pathogenesis and treatment of hypertension? (1996) (23)
Balloon dilatation for renal artery stenosis causing hypertension: criteria, concerns, and cautions. (1980) (22)
Association Between the CYP 3 A 5 Genotype and Blood Pressure (2005) (22)
Atrial natriuretic peptide, renin and aldosterone in obstructive lung disease and heart failure. (1989) (22)
Page kidney: an unusual cause of hypertension. (1976) (22)
Dietary counseling results in effective dietary sodium restriction. (1985) (22)
Improved diagnostic accuracy of renal venous renin ratios with stimulation of renin release. (1977) (21)
The Effects of Minoxidil on Pulmonary and Systemic Hemodynamics in Hypertensive Man (1977) (21)
Results of surgical treatment of renovascular hypertension. (1979) (21)
Evidence against prolactin stimulation of aldosterone in normal human subjects and patients with primary aldosteronism, including a patient with primary aldosteronism and a prolactin-producing pituitary microadenoma. (1977) (21)
Increased incidence of renal cell carcinoma with hypertension. (1977) (20)
Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension (2011) (20)
Diurnal blood pressure in patients with mild‐to‐moderate hypertension treated with once‐daily benazepril hydrochloride (1990) (20)
Detection of adrenal tumors by computerized tomographic scan in endocrine hypertension. (1979) (18)
The renin-angiotensin-aldosterone system and hypertension in primary hyperparathyroidism. (1982) (18)
Unilateral hypersecretion of aldosterone associated with adrenal hyperplasia as a cause of primary aldosteronism. (1983) (17)
Angiographic assessment of renal artery pathology: how reliable? (1983) (17)
The influence of blood pressure and carbohydrate tolerance on vascular compliance in humans. (2002) (17)
OR-55: Comparison of eplerenone and losartan in patients with low-renin hypertension (2002) (17)
Do no harm. Antihypertensive therapy and the 'J' curve. (1992) (16)
Blood pressure response to sodium restriction and potassium supplementation in healthy normotensive children. (1986) (16)
Renal vascular hypertension. Surgery vs. dilation. (1986) (15)
Journal of the American Society of Hypertension. From the editor. (2013) (15)
Hypertension detection, treatment and control: a call to action for cardiovascular specialists. (1999) (15)
Sodium, potassium, and blood pressure. (1997) (14)
Hyperaldosteronism due to unsuspected adrenal carcinoma: discovery during investigation of hypertension in a young woman. (1981) (14)
Decreases in renin and aldosterone secretion in alloxan diabetes: an effect of insulin deficiency. (1985) (14)
Primary aldosteronism: diagnosis and differentiation of subtypes. (1984) (14)
Eplerenone: a new selective aldosterone receptor antagonist. (2004) (14)
Percutaneous transluminal angioplasty in complicated renal vascular hypertension. (1986) (14)
Long-term follow-up of participants in clinical studies. (2002) (13)
More on the sodium saga. (2004) (12)
The relationship of sodium balance and concomitant diuretic therapy to blood pressure response with calcium channel entry blockers. (1991) (11)
The use of multi-media motivation in enhancing compliance of hypertensives discovered at a screening operation. (1979) (11)
Lowering blood pressure in patients without affecting quality of life. (1989) (11)
Is salt-sensitivity of blood pressure a reproducible phenomenon-commentary. (1996) (10)
The effect of dietary interventions to reduce blood pressure in normal humans. (1989) (10)
Optimizing cardiovascular risk reduction during antihypertensive therapy. (1990) (10)
Primary aldosteronism. The etiologic spectrum of disorders and their clinical differentiation. (1982) (10)
Renal artery stenosis and hypertension (1983) (10)
Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. (2010) (10)
Cardiovascular risk factors and antihypertensive therapy. (1988) (9)
Doxazosin lowers blood pressure and improves insulin responses to a glucose load with no changes in tyrosine kinase activity or insulin binding. (1995) (9)
M and L forms of 18-hydroxy-11-deoxycorticosterone and 18-hydroxycorticosterone: factors influencing conversion, stability and immunological properties. (1979) (8)
Comparative efficacy and safety of combination aliskiren/amlodipine and amlodipine monotherapy in African Americans with stage 2 hypertension and obesity or metabolic syndrome. (2011) (8)
Genetic and environmental approaches to the prevention of hypertension (1989) (8)
Blood Pressure Control with Amlodipine Add-on Therapy in Patients with Hypertension and Diabetes: Results of the Amlodipine Diabetic Hypertension Efficacy Response Evaluation Trial (2008) (8)
The effect of oxygen with exercise on atrial natriuretic peptide in chronic obstructive lung disease. (1992) (8)
Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases. (2006) (8)
The renin angiotensin aldosterone system and frusemide response in congestive heart failure. (1995) (8)
Some Evidence for Interrelationship of Histamine and Prostaglandin on Renal Function (1979) (7)
Achieving blood pressure goal: initial therapy with valsartan/hydrochlorothiazide combination compared with monotherapy (2010) (7)
Additive effects of diuretics or sodium restriction with calcium channel blockers in the treatment of hypertension. (1988) (7)
Estrogens, salt, blood pressure, and cardiovascular disease in women: how do we interpret the data? (2006) (7)
Double-blind, placebo-controlled trial of twice-daily nifedipine as a step-2 agent in mild essential hypertension. (1987) (6)
Hemodynamic, renal, and hormonal responses to lower body positive pressure in human subjects. (1996) (6)
Salt and blood pressure (2000) (6)
Treatment of Renal Vascular Hypertension: A Comparison of Patients Treated by Surgery or by Percutaneous Transluminal Angioplasty (1983) (6)
pH-independent inhibition of plasma angiotensin I degradation: implications for renin assay. (1979) (6)
More spice on the salt debate. (1997) (6)
Effects of histamine-receptor antagonists on histamine-stimulated renin secretion. (1986) (6)
Oral contraceptives and hypertension (1975) (6)
PREOPERATIVE DISTINCTION OF ADENOMA FROM HYPERPLASIA IN PRIMARY ALDOSTERONISM (1979) (5)
Sodium intake alters the effects of norepinephrine on the renin system and the kidney. (1981) (5)
Differentiation of Mineralocorticoid-induced Hypertension (1983) (5)
Primary aldosteronism: effects of inhibition of ACTH and potassium administration on plasma aldosterone concentration. (1982) (5)
Angiotensin-converting enzyme inhibitors. (1987) (4)
Can Essential Hypertension Be Subclassified With Respect to Mechanism? (1991) (4)
Cost effectiveness in the detection of renal artery stenosis (1988) (4)
Erythrocyte Sodium Transport and Blood Pressure in White Subjects (1989) (4)
Is salt sensitivity of blood pressure linked to the cardiometabolic syndrome? (2006) (4)
The cold pressor test: a new predictor of future hypertension? (2008) (4)
Potential benefit of combination therapy with diuretics and beta blockers having intrinsic sympathomimetic activity. (1990) (4)
Effect of sulfhydryl reagents on the enzymatic activity of human renin: implications for renin assay. (1980) (4)
Is the correlation between sodium-lithium countertransport and sodium-potassium cotransport an artifact of methodology? (1986) (4)
The use of selective aldosterone antagonists (2004) (4)
COMBINATION ALISKIREN+AMLODIPINE IS MORE EFFECTIVE THAN AMLODIPINE MONOTHERAPY IN MALE AND FEMALE AFRICAN AMERICAN SUBJECTS WITH STAGE 2 HYPERTENSION: PP.5.186 (2010) (4)
DETECTION OF ADRENAL TUMORS BY COMPUTERIZED TOMOGRAPHIC SCAN IN ENDOCRINE HYPERTENSION (1980) (3)
Transluminal balloon dilatation of renal artery stenosis causing hypertension: 18 months' experience. (1980) (3)
Blood Pressure in Sodium Fed Humans (1981) (3)
Dynamic response of active and inactive renin in normal and hypertensive humans. (1977) (3)
ALISKIREN+AMLODIPINE COMBINATION REDUCES CENTRAL BLOOD PRESSURE MORE THAN AMLODIPINE ALONE IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION: PP.5.171 (2010) (3)
Calcium antagonists for the treatment of systemic hypertension. (1992) (3)
Cardiovascular, humoral, and renal effects of phenoxybenzamine in hypertension. (1983) (3)
COMBINATION ALISKIREN+AMLODIPINE PROVIDES GREATER REDUCTIONS IN CLINIC AND 24-HOUR AMBULATORY BLOOD PRESSURES THAN AMLODIPINE ALONE IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION: PP.5.187 (2010) (3)
Salt sensitivity and the blood pressure response to verapamil. (1994) (3)
More novel effects of diet on blood pressure and lipids. (2005) (3)
Mineralocorticoids and blood pressure. (1994) (3)
Restoration of renin-aldosterone dynamics to normal following surgery in primary aldosteronism. (1982) (3)
Is primary aldosteronism a benign disorder? Old evidence reconfirmed. (2006) (3)
Differences between adrenal adenoma causing primary aldosteronism and other adrenal tissues in the incorporation of labeled steroid precursors into their products (1980) (3)
Computerized tomographic scanning and primary aldosteronism. (1979) (3)
Early Morning Variation in Plasma Renin Activity in Normal, Recumbent Humans (1972) (3)
Prevalence of Secondary Hypertension in the Hypertension Detection and Follow-up Program (1985) (3)
The salt-blood pressure controversy: What are the issues? (1999) (3)
Angiotensin converting enzyme inhibitors in the treatment of hypertension: Efficacy, metabolic effects and side effects (2005) (3)
Salt and blood pressure: What’s new? (2001) (3)
Are children doomed by what they eat and drink? (2008) (3)
Saline suppression of plasma aldosterone and plasma renin activity in hypertension. (1971) (3)
Pheochromocytoma presenting as middeldorpf tumor: case report. (1978) (2)
Screening for aldosteronism. (1980) (2)
Salt restriction in the treatment of isolated systolic and combined hypertension: is that enough? (2005) (2)
P-498: Blood pressure response of eplerenone according to baseline characteristics (2003) (2)
The Effect of Age and Norepinephrine on Renin Release by Rat Kidney Slices In Vitro 1 (1976) (2)
Genetic Aspects of Blood Pressure Sensitivity to Sodium (1989) (2)
ARE RACIAL DIFFERENCES IN SODIUM AND WATER HANDLING AT NIGHT RELATED TO DIFFERENCES IN THE SUSCEPTIBILITY TO HYPERTENSION?: P2.229 (2004) (2)
Metabolic and blood pressure effects of angiotensin converting enzyme inhibitors in mild-to-moderate American hypertensives. (1987) (2)
Diuretic responsiveness of blood pressure in the elderly. (1988) (2)
Metabolic considerations in the treatment of the black hypertensive (1989) (2)
Racial differences in antihypertensive therapy: Evidence and implications (1990) (2)
Renin-Angiotensin-Aldosterone System (2009) (2)
The Use of Aldosterone Receptor Blockers in the Treatment of Hypertension (2004) (2)
K17 The use of a reduced sodium salt containing potassium and magnesium as an anjunctive approach to treatment of hypertension with antihypertensive medications (1997) (2)
Obesity, blood pressure, and renal sodium handling (1999) (2)
Unilateral renal vascular hypertension: surgery vs. dilation. (1982) (1)
Evaluation of patients for secondary hypertension. (1977) (1)
Long renal arteries: too much of a good thing? (2005) (1)
O-16: The relationships between age, gender and blood pressure and vascular compliance and resisitance in normal and hypertensive humans (2001) (1)
2010 World Kidney Day report. (2010) (1)
Sodium homeostasis in primary and secondary forms of hypertension. (1995) (1)
Book ReviewArterial Pressure and Hypertension (1981) (1)
Primary Aldosteronism: Effects of Inhibition of ACTH and Potassium Administration on Plasma Aldosterone Concentration (1982) (1)
Hypertension in the elderly. (1992) (1)
Determinants of Exaggerated Natriuresis in Arterial Hypertension (1984) (1)
COMBINATION ALISKIREN+AMLODIPINE PROVIDES GREATER BLOOD PRESSURE REDUCTION THAN AMLODIPINE ALONE IN AFRICAN AMERICANS WITH STAGE 2 HYPERTENSION AND OBESITY OR METABOLIC SYNDROME: PP.5.173 (2010) (1)
Neurohumoral and metabolic advantages of angiotensin converting enzyme inhibitors in the treatment of hypertension and other cardiovascular diseases (1988) (1)
Is There a PGE-Renin Feedback Control System in the Canine Kidney? (1978) (1)
Hypertension in Blacks: Should It Be Treated Differently? (1993) (1)
Chapter 48 – Initial Choices in the Treatment of Hypertension (2005) (1)
Effects of Calcium Channel Blockade with Nitrendipine on Sodium Homeostasis, the Renin-angiotensin System, and the Sympathetic Nervous System in Man (1985) (1)
Is Salt Restriction Relevant and Feasible as Adjunctive Treatment of Hypertension? (1990) (1)
Measurement of renin in segmental renal veins of hypertensives. (1983) (1)
Dietary sodium and blood pressure. (1986) (1)
Diagnosis, localization, and treatment of primary aldosteronism. (1977) (1)
Present status: sodium and hypertension (1990) (1)
Percutaneous transluminal dilatation or surgery in the management of renal vascular hypertension? (1981) (1)
Blood-pressure-related risk factors, stroke, and cognitive function: What are the relationships and what can we do about them? (2003) (1)
Hypertensive rat model. (2013) (1)
Hypertension screening, detection, treatment and follow-up: the Indiana experience. (1977) (1)
Examined mice having the angiotensin converting enzyme (ACE)-2 gene knock-out in comparison to wild-type mice. (2013) (0)
The issue of initiating drug therapy for uncomplicated hypertensive patients. (2011) (0)
From the editor. (2009) (0)
Board of Directors and Membership Benefits (2011) (0)
Authors' response (2011) (0)
P-226 MP-27: Efficacy of ACE inhibitor/CCB vs. ACE inhibitor/diuretic fixed combination therapy for the treatment of essential hypertension (2005) (0)
From the editor. (2014) (0)
From the editor. (2011) (0)
More on cost effectiveness in detecting renal artery stenosis (2007) (0)
From the editor. (2014) (0)
Screening, diagnosis, and treatment of secondary hypertension. (1984) (0)
COMPARISON OFCAPTOPRILAND HYDROCHLOROTHIAZIDE ALONE AND INCOMBINATION INMILDTO MODERATE ESSENTIALHYPERTENSION (1982) (0)
Wednesday May 28, Ballroom A, 8:30 am Two Dialogues on Treating Hypertension: Lifestyle changes (1997) (0)
From the editor. (2014) (0)
The potential role of intracellular angiotensin II. (2013) (0)
Salt intake and blood pressure in humans. (1989) (0)
From the editor. (2008) (0)
Book Review Stroke in Blacks: A guide to management and prevention Edited by R.F. Gillum, P.B. Gorelick, and E.S. Cooper. 230 pp. New York, Karger, 1999. $95. 3-8055-6713-8 (2000) (0)
Introduction: Questions, Current Knowledge, and Clinical Implications (1985) (0)
Effect of plasma storage on erythrocyte sodium pump measurements. (1986) (0)
58 Hypertensive Encephalopathy (2003) (0)
From The Editor (2008) (0)
Sodium and Other Dietary Factors (2001) (0)
The Effects of Angiotensin-Converting Enzyme Inhibition on Sodium Handling in Patients with Advanced Chronic (1987) (0)
Serial publication of sections of the American Society of Hypertension (ASH) self-assessment manual. (2014) (0)
Occupational stress. (2012) (0)
From the editor. (2008) (0)
From the editor. Hypertension. (2010) (0)
The search for curable forms of hypertension: who, when and how. (1983) (0)
MINERALS AND HYPERTENSION : FACTS AND FICTION (1999) (0)
From the editor. (2014) (0)
A Statement of the Nutrition Committee of the American Heart Association (2005) (0)
From the editor. (2009) (0)
Renovascular hypertension. Introduction: questions, current knowledge, and clinical implications. (1985) (0)
Is the vasoconstriction of chronic heart failure related to the renin angiotensin system (1980) (0)
Chapter 79 – Aggressive Blood Pressure Targets: Developing Effective Algorithms (2005) (0)
Peripheral plasma renin levels in hypertension. (1975) (0)
ChrOnOtheraPy With raMiPril in hyPertenSiVe PatientS: ChanGeS in the aWaKe/aSleeP BlOOD PreSSure ratiO aS a FunCtiOn OF the tiMe OF aDMiniStratiOn (2011) (0)
The BookshelfHYPERTENSIVE EMERGENCIESE.D. Hoffer, G.O. Barnett, HYPERTENSIVE EMERGENCIES, Williams and Wilkins Electronic Media, Boston (1984), IBM P.C. diskette (1986) (0)
From the editor. (2010) (0)
Book ReviewHypertension in Pregnancy: Concepts and management (1981) (0)
Honoring the 25(th) anniversary of the American Society of Hypertension. (2010) (0)
New techniques in the diagnosis and treatment of hypertension. (1973) (0)
Hypertension research. (2014) (0)
Antihypertensive Drugs and Pharmacology (2008) (0)
Circadian Rhytlhm of Plasma Aldosterone Concentration in Patients with Primary Aldosteronism (2013) (0)
Letter from the editor. (2007) (0)
The silent, endemic disease--hypertension. (1977) (0)
From the Editor. (2014) (0)
From the editor. (2011) (0)
Age, Pulse Pressure and Salt Sensitivity of Blood Pressure Increase the Risk of Death in Normal and Hypertensive Humans. (2000) (0)
TheUseofMulti-Media Motivation InEnhancing Compliance ofHypertensives Discovered ata Screening Operation (1979) (0)
From the editor. (2012) (0)
Estrogens and hypertension. (1982) (0)
Hypertension in special populations. (2012) (0)
From the editor. (2011) (0)
Commentary 2 (2012) (0)
Lifestyle Modification and Nonpharmacologic Therapy for Hypertension: What Works and What Does Not (1993) (0)
From the editor. (2009) (0)
From the editor. (2009) (0)
Echocardiographic assessment of left ventricular response to extremes of salt intake in normo-tensive man (1978) (0)
From the editor. (2007) (0)
Hypertension management: differing points of view. Should we routinely measure renin levels to diagnose and treat patients with hypertension? The argument against. (2005) (0)
Hypertension: the sodium connection. (1988) (0)
Advances in non-pharmacologic treatment of hypertension: a new approach to the problem of effective dietary sodium restriction. 2. Dietary instruction. (1985) (0)
The development of reduced nephron number. (2014) (0)
Clinical Course and Laboratory Data in Hypertension Associated with Oral Contraceptives (1969) (0)
Contraceptive-Induced Hypertension: A Potentially Curable Form of Hypertension. (1969) (0)
Lipids: Results of the OmniHeart Randomized Trial Carbohydrate Intake on Blood Pressure and Serum Effects of Protein, Monounsaturated Fat, and (2010) (0)
From the editor. (2011) (0)
Which renal vascular hypertension was induced. (2013) (0)
Heterogeneity in blood pressure response to salt in humans: definitions, demographics, mechanisms and implications. (1996) (0)
Antihypertensive therapy: a mechanistic approach. (1983) (0)
From the editor. (2007) (0)
Estrogens and blood pressure. (1977) (0)
A038: Comparison of the efficacy and tolerability of candesartan cilexetil and amlodipine in patients with mild systemic hypertension (CASTLE study) (2000) (0)
Estrogen-induced hypertension. (1976) (0)
From the editor. (2010) (0)
Blood Pressure, cerebrovascular disease, and stroke (2003) (0)
Editorial - from the editor (2000) (0)
From the editor. (2008) (0)
From the editor. (2010) (0)
That Enough? Salt Restriction in the Treatment of Isolated Systolic and Combined Hypertension : Is (2013) (0)
Metabolic advantages of ACE inhibition in combination therapy for hypertension (1987) (0)
From the editor. (2012) (0)
Advances in non-pharmacologic treatment of hypertension: a new approach to the problem of effective dietary sodium restriction. 3. Food preparation. (1986) (0)
From the editor. (2011) (0)
Workshop Epidemiology and Classification of Hypertension: Participants (1991) (0)
Aldosteronism updated. (1973) (0)
A060: Amlodipine VS losartan in the treatment of mild to moderately severe hypertension (2000) (0)
From the editor. (2013) (0)
Sodium and Other Dietary Factors in Hypertension (2001) (0)
Evaluation of patients for secondary hypertension. (1979) (0)
From the editor. (2014) (0)
From the editor. (2008) (0)
From the editor. (2007) (0)
Workshop : epidemiology and classification of hypertension (1991) (0)
From the editor. (2012) (0)
From the editor. (2009) (0)
From the editor. (2009) (0)
From the editor. (2008) (0)
From the editor. (2014) (0)
Natriuretic Responsesin Labile Hypertension (1982) (0)
Advances in non-pharmacologic treatment of hypertension: a new approach to the problem of effective dietary sodium restriction. 1. Sodium in the diet: patient compliance. (1985) (0)
Modest dietary sodium restriction reduces antihypertensive medication (1985) (0)
From the editor. (2014) (0)
INCREASE IN PLASMA NOREPINEPHRINE DURING PRAZOSIN THERAPY FOR CONGESTIVE HEART FAILURE (1981) (0)
Norman M. Kaplan: January 2, 1931-April 5, 2020. (2020) (0)
From the editor. (2007) (0)
effects in hypertension. Influence of an angiotensin converting-enzyme inhibitor on diuretic-induced metabolic (2013) (0)
From the editor. (2008) (0)
JNC VI: what’s new and why? (1998) (0)
From the editor. (2012) (0)
From the editor. (2014) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Myron H. Weinberger?

Myron H. Weinberger is affiliated with the following schools: